[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338056-105":59,"doc-detail-338056-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diffractaic-acid-exerts-anti-cancer-effects-on-hepatocellular-carcinoma-hepg2-cells-by-inducing-apoptosis-and-suppressing-migration-through-targeting-thioredoxin-reductase-1","Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1","","Hepatocellular carcinoma (HCC) is a highly prevalent malignancy, and limited drug options with significant side effects make new chemotherapeutic strategies essential. This study evaluates diffractaic acid (DA), a lichen secondary metabolite, for anticancer activity on HepG2 cells and examines whether effects are mediated by inhibiting thioredoxin reductase 1 (TRXR1). Results show DA cytotoxicity (IC50 78.07 µg/mL at 48 h), induction of late apoptosis/necrosis, reduced cell migration, P53 upregulation, and TRXR1 inhibition confirmed by gene/protein expression and enzyme activity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diffractaic-acid-exerts-anti-cancer-effects-on-hepatocellular-carcinoma-hepg2-cells-by-inducing-apoptosis-and-suppressing-migration-through-targeting-thioredoxin-reductase-1/338056/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diffractaic-acid-exerts-anti-cancer-effects-on-hepatocellular-carcinoma-hepg2-cells-by-inducing-apoptosis-and-suppressing-migration-through-targeting-thioredoxin-reductase-1/338056.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What anticancer effect does diffractaic acid show on HepG2 cells?","Question",{"text":112,"@type":113},"Diffractaic acid exhibits strong cytotoxicity, induces late apoptotic and necrotic effects, and suppresses migration in HepG2 cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the anticancer activity of diffractaic acid linked to thioredoxin reductase 1?",{"text":117,"@type":113},"The study shows increased TRXR1 gene and protein expression but inhibited TRXR1 enzyme activity, indicating that DA targets TRXR1 to exert anticancer effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What changes are observed in apoptosis- and migration-related molecular markers?",{"text":121,"@type":113},"DA upregulates the P53 gene without altering the BAX/BCL2 ratio, and it strongly reduces cell migration as shown by the wound healing assay.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338056,1790119416,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Naunyn-Schmiedeberg's Archives of Pharmacology (2024) 397:5745–5755 [https://doi.org/10.1007/s00210-024-02980-5](https://doi.org/10.1007/s00210-024-02980-5)  \nDiffractaic acid exerts anti‑cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1  \nEmine Karaca Sulukoğlu1,2,3 · Şükran Günaydın1,3,4 · Şeyda Nur Kalın1,3 · Ahmet Altay5 · Harun Budak1  \nReceived: 13 October 2023 / Accepted: 24 January 2024 / Published online: 3 February 2024 © The Author(s) 2024  \nAbstract  \nHepatocellular carcinoma (HCC) represents one of the most common malignant tumors worldwide. Due to the limited number of available drugs and their side effects, the development of new chemotherapeutic strategies for HCC treatment has become increasingly important. This study is aimed at investigating whether diffractaic acid (DA), one of the secondary metabolites of lichen, exhibits a potential anticancer effect on HepG2 cells and whether its anticancer effect is mediated by inhibition of thioredoxin reductase 1 (TRXR1), which is a target of chemotherapeutic strategies due to overexpression in tumor cells including HCC. XTT assay results showed that DA exhibited strong cytotoxicity on HepG2 cells with an IC50 value of 78.07 µg/mL at 48 h. Flow cytometric analysis results revealed that DA displayed late apoptotic and necrotic effects on HepG2 cells. Consistent with these findings, real-time PCR results showed that DA did not alter the BAX/BCL2 ratio in HepG2 cells but upregulated the P53 gene. Moreover, the wound healing assay results revealed a strong anti-migratory effect of DA in HepG2 cells. Real-time PCR and Western blot analyses demonstrated that DA increased TRXR1 gene and protein expression levels, whereas enzyme activity studies disclosed that DA inhibited TRXR1 . These findings suggest that DA has an anticancer effect on HepG2 cells by targeting the enzymatic inhibition of TRXR1 . In conclusion, DA asa TRXR1 inhibitor can be considered an effective chemotherapeutic agent which may be a useful lead compound for the treatment of HCC.  \nKeywords Diffractaic acid · Hepatocellular carcinoma · Cytotoxicity · Thioredoxin reductase 1 · Inhibition · Expression  \n* Ahmet Altay[aaltay@erzincan.edu.tr](aaltay@erzincan.edu.tr)  \n* Harun Budak [hbudak@atauni.edu.tr](hbudak@atauni.edu.tr)  \n1 Science Faculty, Department of Molecular Biology and Genetics, Atatürk University, 25240 Erzurum, Turkey  \n2 Faculty of Science, Department of Molecular Biology and Genetics, Erzurum Technical University,  \n25100 Erzurum, Turkey  \n3 East Anatolia High Technology Application and Research Center, Atatürk University, 25240 Erzurum, Turkey  \n4 Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Kütahya Health Sciences University, 43100 Kütahya, Turkey  \n5 Faculty of Science and Arts, Department of Chemistry, Erzincan Binali Yıldırım University, 24100 Erzincan, Turkey  \nIntroduction  \nHepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and is an important subtype of primary liver cancer with an incidence rate of 90%(Cheng et al. 2016 ; Sung et al. 2021) . Survival rates in HCC patients are quite low and generally have 5-year survival rates (Luo et al. 2017) . The treatment methods developed for HCC are used to prolong survival and improve quality of life (Chabner et al. 2007 ; Gao et al. 2021) . Among these therapies, systemic chemotherapy continues to play a leading role in the treatment of HCC despite its high side effects. Currently, commercial chemotherapeutic agents such as sorafenib and lenvatinib are the mainstay of HCC treatment, but some natural products are under clinical evaluation. Moreover, these natural products such as icaritin, ginsenoside Rg3, and irinotecan have been recognized as potent chemotherapeutic agents for HCC due to their effects on oxidative stress, angiogenesis, and  \nmetastasis (Man et al. 2021) . Ho","cbCaigds8PVhS3i2","https://ap.wps.com/l/cbCaigds8PVhS3i2","pdf",2396968,11,"English","# Abstract\n# Keywords\n# Introduction\n## Hepatocellular carcinoma background and current therapies\n## Lichen secondary metabolites and diffractaic acid\n## Oxidative stress and the thioredoxin system\n# Materials and methods","[{\"question\":\"What anticancer effect does diffractaic acid show on HepG2 cells?\",\"answer\":\"Diffractaic acid exhibits strong cytotoxicity, induces late apoptotic and necrotic effects, and suppresses migration in HepG2 cells.\"},{\"question\":\"How is the anticancer activity of diffractaic acid linked to thioredoxin reductase 1?\",\"answer\":\"The study shows increased TRXR1 gene and protein expression but inhibited TRXR1 enzyme activity, indicating that DA targets TRXR1 to exert anticancer effects.\"},{\"question\":\"What changes are observed in apoptosis- and migration-related molecular markers?\",\"answer\":\"DA upregulates the P53 gene without altering the BAX/BCL2 ratio, and it strongly reduces cell migration as shown by the wound healing assay.\"}]","Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1 | PDF",1790021761,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c94f88733e4835c45d9169602dbe9275.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26355919a574d2f301b3b88c557e0bd3.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb35de53584d071a206a4841763435f1.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f45012cff1f68691b45bf21792b0303.webp",980,1301]